Ziopharm Oncology Appoints Heidi Hagen to Board of Directors - NASDAQ Stock Market -BoardProspects

Ziopharm Oncology Appoints Heidi Hagen to Board of Directors

NASDAQ Stock Market Jun 17 2019 BoardMoves

BOSTON, June 17, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. ("Ziopharm" or "the Company") (Nasdaq:ZIOP), today announced Heidi Hagen, an experienced and entrepreneurial biotechnology operations executive, has been appointed to the Company's Board of Directors effective immediately...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Airbnb Adds Outgoing American Express CEO Kenneth Chenault To Board of Directors also categorized in BoardMoves
- Kenneth A. Burdick and Wendy P. Davidson Elected to First Horizon Board of Directors also published in NASDAQ Stock Market
- Amazon's Board Diversity Push Could Destroy Traditional Retail also categorized in BoardMoves
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- OraSure Technologies Appoints Mara G. Aspinall to Board of Directors also published in NASDAQ Stock Market
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
- Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
- Honest Company Diversifies Its Leadership With A Second Female Board Member also categorized in BoardMoves

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
Topics Mentioned